AbbVie
ABBV
ABBV
2,994 hedge funds and large institutions have $186B invested in AbbVie in 2022 Q2 according to their latest regulatory filings, with 129 funds opening new positions, 1,151 increasing their positions, 1,320 reducing their positions, and 138 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
7% less first-time investments, than exits
New positions opened: 129 | Existing positions closed: 138
2% less funds holding
Funds holding: 3,043 → 2,994 (-49)
13% less repeat investments, than reductions
Existing positions increased: 1,151 | Existing positions reduced: 1,320
Holders
2,994
Holding in Top 10
329
Calls
$3.01B
Puts
$2.54B
Top Buyers
| 1 | +$1.94B | |
| 2 | +$1.41B | |
| 3 | +$1.1B | |
| 4 |
BlackRock
New York
|
+$776M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$469M |
Top Sellers
| 1 | -$907M | |
| 2 | -$464M | |
| 3 | -$377M | |
| 4 |
Two Sigma Advisers
New York
|
-$284M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$261M |